Efficacy and Safety of LCZ696 in Comparison to Olmesartan in Elderly Patients With Essential Hypertension
Clinical trial NCT01615198 · COMPLETED
Trial details
- NCT number
- NCT01615198
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-07-01
- Enrollment
- 588
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.